Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass
暂无分享,去创建一个
S. Dhein | I. Dähnert | N. Klein | A. Salameh
[1] Sherif Hafez,et al. Response to Letter Regarding Article, "Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke". , 2016, Stroke.
[2] F. Mohr,et al. Epigallocatechin gallate attenuates cardiopulmonary bypass-associated lung injury. , 2016, The Journal of surgical research.
[3] S. Hyon,et al. Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass. , 2016, The Annals of thoracic surgery.
[4] Hao Wang,et al. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy , 2016, Oncotarget.
[5] F. Sharp,et al. Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke , 2016, Front. Cell. Neurosci..
[6] Sherif Hafez,et al. Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke , 2016, Stroke.
[7] G. Faggian,et al. Hemoglobin Concentration Affects Electroencephalogram During Cardiopulmonary Bypass: An Indication for Neuro-Protective Values. , 2016, Artificial organs.
[8] Z. Qin,et al. Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery , 2015, Chinese medical journal.
[9] J. Klopfenstein,et al. Matrix Metalloproteinase-12 Induces Blood–Brain Barrier Damage After Focal Cerebral Ischemia , 2015, Stroke.
[10] S. Dhein,et al. Hippocampal Neuroprotection by Minocycline and Epigallo‐Catechin‐3‐Gallate Against Cardiopulmonary Bypass‐Associated Injury , 2015, Brain pathology.
[11] T. Ottens,et al. Low incidence of early postoperative cerebral edema after coronary artery bypass grafting. , 2015, Journal of cardiothoracic and vascular anesthesia.
[12] J. Torres,et al. Neuroprotection After Major Cardiovascular Surgery , 2015, Current Treatment Options in Neurology.
[13] S. Gill,et al. The role of TIMPs in regulation of extracellular matrix proteolysis. , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[14] A. Jovanovic,et al. Mild hypoxia in vivo regulates cardioprotective SUR2A: A role for Akt and LDH , 2015, Biochimica et biophysica acta.
[15] A. Brassai,et al. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity , 2015, Brain Research Bulletin.
[16] F. Liu,et al. The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro , 2015, Free radical research.
[17] A. Blann,et al. Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery , 2015, British journal of biomedical science.
[18] A. Jovanovic,et al. Upregulation of cardioprotective SUR2A by sub-hypoxic drop in oxygen , 2014, Biochimica et biophysica acta.
[19] T. Dawson,et al. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis , 2014, Proceedings of the National Academy of Sciences.
[20] B. Rybojad,et al. Disturbance in venous outflow from the cerebral circulation intensifies the release of blood-brain barrier injury biomarkers in patients undergoing cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.
[21] P. Kochanek,et al. Minocycline attenuates brain tissue levels of TNF-α produced by neurons after prolonged hypothermic cardiac arrest in rats. , 2014, Resuscitation.
[22] V. Borutaite,et al. In the eye of the storm: mitochondrial damage during heart and brain ischaemia , 2013, The FEBS journal.
[23] M. Aldemir,et al. Comparison of the Effects of Desflurane and Propofol Anesthesia on the Inflammatory Response and S100β Protein During Coronary Artery Bypass Grafting , 2013, Inflammation.
[24] E. Şener,et al. Comparing S-100 beta protein levels and neurocognitive functions between patients undergoing on-pump and off-pump coronary artery bypass grafting. , 2013, The Journal of surgical research.
[25] Yun Lin Ang,et al. Cognitive outcome after on- and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. , 2013, Journal of cardiothoracic and vascular anesthesia.
[26] J. Coselli,et al. A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. , 2013, Annals of cardiothoracic surgery.
[27] Tie-zheng Zhang,et al. Penehyclidine hydrochloride attenuates the cerebral injury in a rat model of cardiopulmonary bypass. , 2013, Canadian journal of physiology and pharmacology.
[28] Shengshou Hu,et al. Ulinastatin as a neuroprotective and anti‐inflammatory agent in infant piglets model undergoing surgery on hypothermic low‐flow cardiopulmonary bypass , 2013, Paediatric anaesthesia.
[29] S. Yao,et al. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery. , 2013, British journal of clinical pharmacology.
[30] Randall B. Griepp,et al. Hypothermia for aortic surgery. , 2013, The Journal of thoracic and cardiovascular surgery.
[31] F. Mohr,et al. Cerebral Protection during Controlled Hypoperfusion in a Piglet Model: Comparison of Moderate (25°C) versus Deep (18°C) Hypothermia at Various Flow Rates Using Intraoperative Measurements and Ex vivo Investigation , 2012, Thoracic and Cardiovascular Surgeon.
[32] J. Tijssen,et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. , 2012, JAMA.
[33] M. Pugliese,et al. ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia–ischemia in rats , 2012, Experimental Neurology.
[34] C. Glasier,et al. Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: A pilot randomized, double-blind, placebo-controlled trial , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[35] Y. Zorlutuna,et al. Clinical evaluation of leukocyte filtration as an alternative anti-inflammatory strategy to aprotinin in high-risk patients undergoing coronary revascularization , 2012, Surgery Today.
[36] Z. Dai,et al. Up-regulation of hypoxia inducible factor-1α by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells , 2012, Journal of Experimental & Clinical Cancer Research.
[37] Neetu Singh,et al. Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia , 2012, Cellular and Molecular Neurobiology.
[38] S. Gandhi,et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children--a randomized trial. , 2013, The Journal of thoracic and cardiovascular surgery.
[39] B. Lima,et al. Results of Proximal Arch Replacement Using Deep Hypothermia for Circulatory Arrest: Is Moderate Hypothermia Really Justifiable? , 2011, The American surgeon.
[40] D. Low,et al. Neurological Complications of Thoracic Endovascular Aortic Repair , 2011, Seminars in cardiothoracic and vascular anesthesia.
[41] Cheuk-Kwan Sun,et al. Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke , 2011, Journal of Translational Medicine.
[42] Attila Tárnok,et al. Modulation of the cellular and humoral immune response to pediatric open heart surgery by methylprednisolone , 2011, Cytometry. Part B, Clinical cytometry.
[43] E. Pérez-Payá,et al. Tyrosine phosphorylation turns alkaline transition into a biologically relevant process and makes human cytochrome c behave as an anti-apoptotic switch , 2011, JBIC Journal of Biological Inorganic Chemistry.
[44] M. Munir,et al. Clinical effectiveness of centrifugal pump to produce pulsatile flow during cardiopulmonary bypass in patients undergoing cardiac surgery. , 2011, Artificial organs.
[45] G. Rakhorst,et al. Reply to the Editor: Clinical Effectiveness of Centrifugal Pump to Produce Pulsatile Flow During Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery , 2011 .
[46] H. Vélez,et al. Lowest safe hematocrit level on cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. , 2011, Boletin de la Asociacion Medica de Puerto Rico.
[47] C. Long,et al. Effects of pulsatile and nonpulsatile perfusion on cerebral regional oxygen saturation and endothelin-1 in tetralogy of fallot infants. , 2011, Artificial organs.
[48] H. Sievers,et al. Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery. , 2011, Interactive cardiovascular and thoracic surgery.
[49] G. Vingerhoets,et al. The effect of CABG on neurocognitive functioning , 2010, Acta cardiologica.
[50] M. Bunc,et al. Importance of erythropoietin in brain protection after cardiac surgery: a pilot study. , 2010, The heart surgery forum.
[51] J. Gagné,et al. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry , 2010, Proteome Science.
[52] H. Reichmann,et al. Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke , 2009, Stroke.
[53] M. Elahi,et al. Inspired nitric oxide and modulation of oxidative stress during cardiac surgery. , 2009, Current drug safety.
[54] A. Jekabsone,et al. Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release , 2009, Journal of Biomedical Science.
[55] E. Tireli,et al. Influence of Methylprednisolone on Levels of Neuron‐Specific Enolase in Cardiac Surgery: A Corticosteroid Derivative to Decrease Possible Neuronal Damage , 2009, Journal of cardiac surgery.
[56] L. Rasmussen,et al. Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[57] K. Akinosoglou,et al. The methodologies of hypothermic circulatory arrest and of antegrade and retrograde cerebral perfusion for aortic arch surgery. , 2008, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[58] Somsuvra B. Ghatak,et al. Pexelizumab and its role in the treatment of myocardial infarction and in coronary artery bypass graft surgery: a review. , 2008, Recent patents on cardiovascular drug discovery.
[59] Joel D. Graham,et al. Reducing the Effects of the Systemic Inflammatory Response to Cardiopulmonary Bypass: Can Single Dose Steroids Blunt Systemic Inflammatory Response Syndrome? , 2008, ASAIO journal.
[60] D. Sulemanji,et al. Dexmedetomidine during coronary artery bypass grafting surgery: is it neuroprotective? – A preliminary study , 2007, Acta anaesthesiologica Scandinavica.
[61] D. Heal,et al. KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. , 2006, CNS drug reviews.
[62] M. Bernaudin,et al. Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1α (HIF-1α) protein following focal cerebral ischemia in rats , 2006, Neurochemistry International.
[63] J. Simard,et al. Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke , 2006, Nature Medicine.
[64] M. Borger,et al. Reducing Cerebral Emboli During Cardiopulmonary Bypass , 2005, Seminars in cardiothoracic and vascular anesthesia.
[65] B. Zhong,et al. Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). , 2005, Bioorganic & medicinal chemistry letters.
[66] G. Semenza,et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.
[67] D. Bainbridge,et al. Does Off-pump Coronary Artery Bypass Reduce Mortality, Morbidity, and Resource Utilization When Compared with Conventional Coronary Artery Bypass? A Meta-analysis of Randomized Trials , 2005, Anesthesiology.
[68] G. Murphy,et al. Side Effects of Cardiopulmonary Bypass: , 2004, Journal of cardiac surgery.
[69] J. Copeland,et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[70] J. Maessen,et al. Neurological complications after coronary artery bypass grafting related to the performance of cardiopulmonary bypass. , 2004, Chest.
[71] N. Gormus,et al. The cerebroprotective effects of pentoxifylline and aprotinin during cardiopulmonary bypass in dogs , 2004, Perfusion.
[72] Volkmar Falk,et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. , 2003, The Annals of thoracic surgery.
[73] S Karthikeyan,et al. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomised controlled trial , 2002, BMJ : British Medical Journal.
[74] G. Vingerhoets,et al. Short-term and long-term neurocognitive outcome in on-pump versus off-pump CABG. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[75] A. Ündar,et al. Do S100β protein level increases due to inflammation during cardiopulmonary bypass occur without any neurological deficit? , 2002, Perfusion.
[76] Karel G M Moons,et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. , 2002, JAMA.
[77] Takashi Sato,et al. β-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia , 2002 .
[78] P. Rosseel,et al. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. , 2002, British journal of anaesthesia.
[79] M. Beach,et al. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. , 2002, Journal of cardiothoracic and vascular anesthesia.
[80] W. Baumgartner,et al. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. , 2001, The Annals of thoracic surgery.
[81] G. Semenza,et al. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.
[82] S. Vogt,et al. Serum S-100beta protein release in coronary artery bypass grafting: laminar versus pulsatile flow. , 2001, The Thoracic and cardiovascular surgeon.
[83] V. Jäntti,et al. The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine model. , 2001, The Journal of thoracic and cardiovascular surgery.
[84] C. Elger,et al. Potassium channel openers depolarize hippocampal mitochondria , 2001, Brain Research.
[85] Mark F. Newman,et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. , 2001, The New England journal of medicine.
[86] M. Kelm,et al. Endogenous nitric oxide and myocardial adaptation to ischemia. , 2000, Circulation research.
[87] A. Rajek,et al. Pulsatility does not change cerebral oxygenation during cardiopulmonary bypass , 2000, Acta anaesthesiologica Scandinavica.
[88] Guido Kroemer,et al. Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[89] P. Illés,et al. Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia , 1999, Neuroscience Letters.
[90] M. Jäättelä,et al. Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases , 1998, The EMBO journal.
[91] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[92] S. Snyder,et al. Journal Club: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1998 .
[93] S. Snyder,et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.
[94] R. Weichselbaum,et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[95] T. Orszulak,et al. Effect of pump flow rate on cerebral blood flow during hypothermic cardiopulmonary bypass in adults. , 1997, Journal of cardiothoracic and vascular anesthesia.
[96] B. Ebert,et al. Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.
[97] S. Kourembanas,et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.
[98] C. Cooper,et al. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase , 1994, FEBS letters.
[99] C. Bodian,et al. Hypothermic circulatory arrest in operations on the thoracic aorta. Determinants of operative mortality and neurologic outcome. , 1994, The Journal of thoracic and cardiovascular surgery.
[100] G. Bydder,et al. Brain swelling in first hour after coronary artery bypass surgery , 1993, The Lancet.
[101] K. Suzuki,et al. Substrate specificities and activation mechanisms of matrix metalloproteinases. , 1991, Biochemical Society transactions.
[102] L. Ignarro,et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[103] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[104] G F Cahill,et al. Brain metabolism during fasting. , 1967, The Journal of clinical investigation.
[105] J. H. Gibbon,et al. Application of a mechanical heart and lung apparatus to cardiac surgery. , 1954, Minnesota medicine.
[106] Bigelow Wg. Application of hypothermia to cardiac surgery. , 1954 .
[107] M. DeBakey,et al. SURGICAL CONSIDERATIONS OF INTRATHORACIC ANEURYSMS OF THE AORTA AND GREAT VESSELS , 1952, Annals of surgery.
[108] W. Bayliss. On the local reactions of the arterial wall to changes of internal pressure , 1902, The Journal of physiology.
[109] C. Elsberg. AN EXPERIMENTAL INVESTIGATION OF THE TREATMENT OF WOUNDS OF THE HEART BY MEANS OF SUTURE OF THE HEART MUSCLE , 1899, The Journal of experimental medicine.
[110] Seong‐Ryong Lee,et al. Protective effect of resveratrol against neuronal damage following transient global cerebral ischemia in mice. , 2016, The Journal of nutritional biochemistry.
[111] F. Mohr,et al. Protective effects of pulsatile flow during cardiopulmonary bypass. , 2015, The Annals of thoracic surgery.
[112] F. Mohr,et al. Reno-protective effects of epigallocatechingallate in a small piglet model of extracorporeal circulation. , 2013, Pharmacological research.
[113] K M Taylor,et al. The systemic inflammatory response syndrome and cardiopulmonary bypass. , 2005, International journal of surgery.
[114] R. Baker,et al. The Octopus II stabilizing system: biochemical and neuropsychological outcomes in coronary artery bypass surgery. , 2001, The heart surgery forum.
[115] W. van Oeveren,et al. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[116] Henny H. Billett,et al. hemoglobin and hematocrit , 2022 .
[117] W. G. Bigelow. Application of hypothermia to cardiac surgery. , 1954, Minnesota medicine.